Aminocaproic Acid + Anti Inhibitor Coagulant Complex Interaction
Majorinteraction on record
Description
Systemic antifibrinolytic; increased risk of thrombotic events. Use not recommended within 6-12 hours after FEIBA administration.
Mechanism
Antifibrinolytic mechanism may increase thrombotic risk with FEIBA
Source: NLP:anti-inhibitor coagulant complex